Literature DB >> 11268497

Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies.

L Tamás1, H Kraxner, L Mechtler, G Répássy, O Ribári, A Hirschberg, G Szentkúti, B Járay, Z Szentirmay.   

Abstract

BACKGROUND: The aim of the study was to determine the role of quantitative pathological parameters in prognosis of head and neck malignancies.
MATERIALS AND METHODS: 51 head and neck squamous cell carcinoma patients were examined for mutant p53 gene expression (45 out of 51 patients) by immunohistochemistry and for cellular DNA-content (44 out of 51 patients) using digital picture analyzer. Statistical analysis was performed using BMDP package.
RESULTS: No correlation with prognosis was found for age, sex, localization, T-classification and therapy. There was significant relationship between N-status and overall survival (p = 0.0008). No correlation was found with overall and disease-free survival for either histologic type or grading. P53: No significant correlation was detected with overall survival. A relationship was found between mutant p53 and metastasis-free time (p = 0.06). Ploidy: There were no significant differences between aneuploid and euploid tumors for either disease-free or overall survival. Synthetic (S)-phase fraction: A correlation was found for both survival rates (p = 0.029) and metastasis-free time (p = 0.05). Polyploid fraction (PF): correlation was shown for both overall survival (p = 0.0128) and metastasis-free time (p = 0.0038).
CONCLUSION: There is correlation between p53 overexpression and metastatic potential and there is a significant relationship between SPF and PF value and prognosis (metastasis-free and overall survival) of head and neck cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11268497

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  DNA content heterogeneity in neuroblastoma analyzed by means of image cytometry and its potential significance.

Authors:  Zsombor Melegh; Erzsébet Csernák; Erika Tóth; Zsuzsa Veleczki; Edina Magyarosy; Kálmán Nagy; Zoltán Szentirmay
Journal:  Virchows Arch       Date:  2005-04-13       Impact factor: 4.064

2.  P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.

Authors:  Lun-Xiu Qin; Zhao-You Tang; Zeng-Chen Ma; Zhi-Quan Wu; Xin-Da Zhou; Qing-Hai Ye; Yuan Ji; Li-Wen Huang; Hu-Liang Jia; Hui-Chuan Sun; Lu Wang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 3.  The prognostic molecular markers in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

4.  Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.

Authors:  Gabriella Szentkúti; Kornél Dános; Diána Brauswetter; Gergő Kiszner; Tibor Krenács; László Csákó; Gábor Répássy; László Tamás
Journal:  Pathol Oncol Res       Date:  2014-12-31       Impact factor: 3.201

Review 5.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.